BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29564734)

  • 1. Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.
    Gerogianni K; Tsezou A; Dimas K
    Mol Diagn Ther; 2018 Jun; 22(3):297-314. PubMed ID: 29564734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA alleles and drug hypersensitivity reactions.
    Profaizer T; Eckels D
    Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic markers of severe cutaneous adverse drug reactions.
    Borroni RG
    G Ital Dermatol Venereol; 2014 Apr; 149(2):219-26. PubMed ID: 24819643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation.
    Su SC; Hung SI; Fan WL; Dao RL; Chung WH
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of hypersensitivity drug reactions.
    Negrini S; Becquemont L
    Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening.
    Fernando SL; Broadfoot AJ
    CMAJ; 2010 Mar; 182(5):476-80. PubMed ID: 19933789
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
    Mullan KA; Anderson A; Illing PT; Kwan P; Purcell AW; Mifsud NA
    HLA; 2019 Jun; 93(6):417-435. PubMed ID: 30895730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLAs: Key regulators of T-cell-mediated drug hypersensitivity.
    Redwood AJ; Pavlos RK; White KD; Phillips EJ
    HLA; 2018 Jan; 91(1):3-16. PubMed ID: 29171940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotyping for severe drug hypersensitivity.
    Karlin E; Phillips E
    Curr Allergy Asthma Rep; 2014 Mar; 14(3):418. PubMed ID: 24429903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on HLA alleles associated with adverse drug reactions.
    Fricke-Galindo I; LLerena A; López-López M
    Drug Metab Pers Ther; 2017 May; 32(2):73-87. PubMed ID: 28315856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions.
    Kano Y; Hirahara K; Asano Y; Shiohara T
    Acta Derm Venereol; 2008; 88(6):616-8. PubMed ID: 19002350
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
    Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.
    Lucas A; Nolan D; Mallal S
    J Antimicrob Chemother; 2007 Apr; 59(4):591-3. PubMed ID: 17317695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen-associated drug hypersensitivity.
    Illing PT; Vivian JP; Purcell AW; Rossjohn J; McCluskey J
    Curr Opin Immunol; 2013 Feb; 25(1):81-9. PubMed ID: 23141566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
    Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
    Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.
    Sukasem C; Puangpetch A; Medhasi S; Tassaneeyakul W
    Asian Pac J Allergy Immunol; 2014 Jun; 32(2):111-23. PubMed ID: 25003724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
    Bharadwaj M; Illing P; Theodossis A; Purcell AW; Rossjohn J; McCluskey J
    Annu Rev Pharmacol Toxicol; 2012; 52():401-31. PubMed ID: 22017685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.